Published in J Gen Virol on May 01, 2000
Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J Clin Microbiol (2005) 3.82
Frequency and dynamics of recombination within different species of human enteroviruses. J Virol (2006) 2.64
Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the noncapsid coding region. J Virol (2003) 2.40
Recombination in circulating enteroviruses. J Virol (2003) 2.08
Recombination and selection in the evolution of picornaviruses and other Mammalian positive-stranded RNA viruses. J Virol (2006) 2.05
Arginine-glycine-aspartic acid motif is critical for human parechovirus 1 entry. J Virol (2001) 1.46
The association of recombination events in the founding and emergence of subgenogroup evolutionary lineages of human enterovirus 71. J Virol (2011) 1.40
Transmission networks and population turnover of echovirus 30. J Virol (2008) 1.25
Integrin alpha v beta 6 is an RGD-dependent receptor for coxsackievirus A9. J Virol (2004) 1.16
Molecular epidemiology of echovirus 30: temporal circulation and prevalence of single lineages. J Virol (2002) 1.06
Prospective identification of enteroviruses involved in meningitis in 2006 through direct genotyping in cerebrospinal fluid. J Clin Microbiol (2007) 1.03
FDJS03 isolates causing an outbreak of aseptic meningitis in China that evolved from a distinct Echovirus 30 lineage imported from countries of the Commonwealth of Independent States. J Clin Microbiol (2006) 1.00
Structural and functional analysis of coxsackievirus A9 integrin αvβ6 binding and uncoating. J Virol (2013) 0.92
A highly divergent Encephalomyocarditis virus isolated from nonhuman primates in Singapore. Virol J (2013) 0.91
An outbreak of aseptic meningitis caused by coxsackievirus A9 in Gansu, the People's Republic of China. Virol J (2010) 0.88
Recombination in enteroviruses is a biphasic replicative process involving the generation of greater-than genome length 'imprecise' intermediates. PLoS Pathog (2014) 0.87
Viral meningitis epidemics and a single, recent, recombinant and anthroponotic origin of swine vesicular disease virus. Evol Med Public Health (2015) 0.86
Genetic characterization of a Coxsackie A9 virus associated with aseptic meningitis in Alberta, Canada in 2010. Virol J (2013) 0.84
Typing of enteroviruses by use of microwell oligonucleotide arrays. J Clin Microbiol (2009) 0.83
Endocytosis of integrin-binding human picornaviruses. Adv Virol (2012) 0.82
Phylogenetic patterns of human coxsackievirus B5 arise from population dynamics between two genogroups and reveal evolutionary factors of molecular adaptation and transmission. J Virol (2013) 0.81
Characterization of a novel enterovirus serotype and an enterovirus EV-B93 isolated from acute flaccid paralysis patients. PLoS One (2013) 0.78
Enterovirus Migration Patterns between France and Tunisia. PLoS One (2015) 0.75
Identification of new genotype of Echovirus 19 from children with Acute Flaccid Paralysis in Pakistan. Sci Rep (2015) 0.75
Integrins are not essential for entry of coxsackievirus A9 into SW480 human colon adenocarcinoma cells. Virol J (2016) 0.75
A distinct picornavirus group identified by sequence analysis. Proc Natl Acad Sci U S A (1992) 3.28
Viruses and bacteria in the etiology of the common cold. J Clin Microbiol (1998) 3.24
Evidence of recombination among enteroviruses. J Virol (1999) 2.92
High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill (2010) 2.56
The nucleotide sequence of coxsackievirus A9; implications for receptor binding and enterovirus classification. J Gen Virol (1989) 2.52
Detection of enteroviruses by spot hybridization. J Clin Microbiol (1984) 2.51
Genetic and phylogenetic clustering of enteroviruses. J Gen Virol (1996) 2.31
Molecular and biological characteristics of echovirus 22, a representative of a new picornavirus group. J Virol (1994) 2.27
Human parechoviruses--biology and clinical significance. Rev Med Virol (2000) 2.24
Molecular analysis of coxsackievirus A16 reveals a new genetic group of enteroviruses. Virology (1994) 2.13
Detection of enteroviruses and rhinoviruses in clinical specimens by PCR and liquid-phase hybridization. J Clin Microbiol (1995) 2.10
Molecular comparison of coxsackie A virus serotypes. Virology (1995) 2.00
Entry of coxsackievirus A9 into host cells: specific interactions with alpha v beta 3 integrin, the vitronectin receptor. Virology (1994) 1.96
Parechoviruses, a novel group of human picornaviruses. Ann Med (2001) 1.92
RGD-dependent entry of coxsackievirus A9 into host cells and its bypass after cleavage of VP1 protein by intestinal proteases. J Virol (1991) 1.91
Molecular analysis of human parechovirus type 2 (formerly echovirus 23). J Gen Virol (1998) 1.84
Diagnosis and epidemiology of echovirus 22 infections. Clin Infect Dis (1998) 1.74
Arginine/lysine-rich structural element is involved in interferon-induced nuclear import of STATs. J Biol Chem (2001) 1.68
The major echovirus group is genetically coherent and related to coxsackie B viruses. J Gen Virol (1996) 1.67
Parechoviruses. J Virol (1999) 1.66
Identification of enteroviruses in clinical specimens by competitive PCR followed by genetic typing using sequence analysis. J Clin Microbiol (1996) 1.64
Detection of Chlamydia trachomatis in clinical specimens by nucleic acid spot hybridization. J Gen Microbiol (1985) 1.59
Screening respiratory samples for detection of human rhinoviruses (HRVs) and enteroviruses: comprehensive VP4-VP2 typing reveals high incidence and genetic diversity of HRV species C. J Clin Microbiol (2009) 1.44
The crystal structure of coxsackievirus A9: new insights into the uncoating mechanisms of enteroviruses. Structure (1999) 1.43
The association of recombination events in the founding and emergence of subgenogroup evolutionary lineages of human enterovirus 71. J Virol (2011) 1.40
Entry of human parechovirus 1. J Virol (2001) 1.39
Direct identification of human enterovirus serotypes in cerebrospinal fluid by amplification and sequencing of the VP1 region. J Clin Virol (2009) 1.39
Echoviruses include genetically distinct serotypes. J Gen Virol (1990) 1.36
Replication of measles virus in human lymphocytes. J Exp Med (1985) 1.34
Detection of adenovirus in nasopharyngeal specimens by radioactive and nonradioactive DNA probes. J Clin Microbiol (1985) 1.33
Diagnosis of enterovirus and rhinovirus infections by RT-PCR and time-resolved fluorometry with lanthanide chelate labeled probes. J Med Virol (1999) 1.31
The nucleotide sequences of wild-type coxsackievirus A9 strains imply that an RGD motif in VP1 is functionally significant. J Gen Virol (1992) 1.30
Antigenic properties of human parechovirus 1. J Gen Virol (2000) 1.27
A new picornavirus isolated from bank voles (Clethrionomys glareolus). Virology (1999) 1.26
Transmission networks and population turnover of echovirus 30. J Virol (2008) 1.25
The coxsackievirus A9 RGD motif is not essential for virus viability. J Virol (1995) 1.20
Genetic diversity of enterovirus subgroups. Arch Virol (1989) 1.18
Cell-surface interactions of echovirus 22. J Biol Chem (1997) 1.18
Genetic variation in vivo and proposed functional domains of the 5' noncoding region of poliovirus RNA. J Virol (1992) 1.17
Evolution of poliovirus during an outbreak: sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants. J Gen Virol (1987) 1.14
The genome of echovirus 11. Virus Res (1995) 1.14
Comparison of PCR primer pairs in the detection of human rhinoviruses in nasopharyngeal aspirates. J Virol Methods (1997) 1.14
Analysis and detection of chlamydial DNA. J Gen Microbiol (1984) 1.13
Atypical hand, foot, and mouth disease associated with coxsackievirus A6 infection, Edinburgh, United Kingdom, January to February 2014. Euro Surveill (2014) 1.12
Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: a prospective study. Childhood Diabetes in Finland (DiMe) Study Group. J Med Virol (2000) 1.11
Measles virus activates NF-kappa B and STAT transcription factors and production of IFN-alpha/beta and IL-6 in the human lung epithelial cell line A549. Virology (2001) 1.11
Disease burden of the most commonly detected respiratory viruses in hospitalized patients calculated using the disability adjusted life year (DALY) model. J Clin Virol (2011) 1.09
Antigenic variation among 173 strains of type 3 poliovirus isolated in Finland during the 1984 to 1985 outbreak. J Gen Virol (1988) 1.04
Echovirus 1 infection induces both stress- and growth-activated mitogen-activated protein kinase pathways and regulates the transcription of cellular immediate-early genes. Virology (1998) 1.03
Evolutionary dynamics and temporal/geographical correlates of recombination in the human enterovirus echovirus types 9, 11, and 30. J Virol (2010) 1.03
Antigenic sites of coxsackievirus A9. Virology (1998) 1.02
Detection of adenoviruses in stool specimens by nucleic acid spot hybridization. J Med Virol (1985) 1.01
HA1 domain of influenza A (H3N2) viruses in Finland in 1989-1995: evolution, egg-adaptation and relationship to vaccine strains. Arch Virol (1996) 1.01
Serum 25-hydroxyvitamin D level during early pregnancy and type 1 diabetes risk in the offspring. Diabetologia (2012) 1.00
Recombination dynamics of human parechoviruses: investigation of type-specific differences in frequency and epidemiological correlates. J Gen Virol (2010) 0.99
Coxsackievirus B3 infection in human leukocytes and lymphoid cell lines. Blood (1994) 0.98
Phylogenetic analysis of avian paramyxovirus 1 strains isolated in Finland. Arch Virol (2001) 0.97
Time-resolved fluorometry for the identification of viral DNA in clinical specimens. J Clin Microbiol (1988) 0.96
Relationships between simian and human enteroviruses. J Gen Virol (1999) 0.96
Biology of parainfluenza viruses. Clin Microbiol Rev (1994) 0.95
Release of soluble ICAM-5, a neuronal adhesion molecule, in acute encephalitis. Neurology (2002) 0.94
Susceptibility of human bone marrow cells and hematopoietic cell lines to coxsackievirus B3 infection. J Virol (1996) 0.92
Recent influenza B viruses in Europe: a phylogenetic analysis. Clin Diagn Virol (1996) 0.92
Type 3 poliovirus/Finland/1984 is genetically related to common Mediterranean strains. J Gen Virol (1990) 0.89
Coxsackievirus B3-induced acute pancreatitis: analysis of histopathological and viral parameters in a mouse model. Br J Exp Pathol (1989) 0.89
Effects of echovirus 1 infection on cellular gene expression. Virology (2000) 0.88
Effect of interferon-alpha on measles virus replication in human peripheral blood mononuclear cells. APMIS (1992) 0.88
Induction of neutralizing antibodies by synthetic peptides representing the C terminus of coxsackievirus A9 capsid protein VP1. J Gen Virol (1998) 0.87
Typing of herpes simplex virus isolates with monoclonal antibodies and by nucleic acid spot hybridization. J Virol Methods (1985) 0.87
Measles virus enhances the expression of cellular immediate-early genes and DNA-binding of transcription factor AP-1 in lung epithelial A549 cells. Arch Virol (2002) 0.87
Enterovirus receptors and virus replication in human leukocytes. J Gen Virol (1999) 0.86
Acceptable protective efficacy of influenza vaccination in young military conscripts under circumstances of incomplete antigenic and genetic match. Vaccine (2001) 0.85
Early signal transduction in measles virus-infected lymphocytes is unaltered, but second messengers activate virus replication. J Virol (1991) 0.85
The measles virus-specific protein synthesis of persistently and lytically infected cells studied in vivo and in vitro. Acta Pathol Microbiol Scand B (1981) 0.85
The use of molecular hybridization for demonstration of adenoviruses in human stools. Curr Top Microbiol Immunol (1983) 0.84
Evolution of the HA1 domain of human influenza A (H1N1) virus: loss of glycosylation sites and occurrence of herald and conserved strains. J Gen Virol (1995) 0.84
Foodborne outbreaks of hepatitis A in a low endemic country: an emerging problem? Epidemiol Infect (1998) 0.84
Typing of enteroviruses by use of microwell oligonucleotide arrays. J Clin Microbiol (2009) 0.83
B-cell function in vitro during rubella infection. Infect Immun (1984) 0.83
Mapping of antigenic sites of coxsackievirus B3 by synthetic peptides. APMIS (1993) 0.83
Rhinovirus RNA in the maxillary sinus epithelium of adult patients with acute sinusitis. Clin Infect Dis (2001) 0.82
Role of cytoskeleton components in measles virus replication. Arch Virol (2004) 0.82
Depletion of alphaV integrins from osteosarcoma cells by intracellular antibody expression induces bone differentiation marker genes and suppresses gelatinase (MMP-2) synthesis. Matrix Biol (1999) 0.82
Poliovaccine virus in the cerebrospinal fluid after oral polio vaccination. J Infect (1989) 0.82
Hepatitis A outbreak amongst intravenous amphetamine abusers in Finland. Scand J Infect Dis (1997) 0.81
Experimental myocarditis induced by two different coxsackievirus B3 variants: aspects of pathogenesis and comparison of diagnostic methods. J Med Virol (1995) 0.81
Antiviral treatment with WIN 54 954 reduces mortality in murine coxsackievirus B3 myocarditis. Circulation (1996) 0.79
A population-specific diabetogenic haplotype HLA-A2,Cw1,B56,DR4,DQ8 is associated with high birthweight in Finnish diabetic families. Genes Immun (2008) 0.78
Antibodies to nuclear and smooth muscle antigens in multiple sclerosis and control patients. Acta Neurol Scand (1982) 0.78
Vaccination-induced HI antibody to influenza A(H1N1) viruses in poorly primed adults under circumstances of low antigenic drift. Vaccine (1993) 0.78
Poliovirus type 3/Saukett: antigenic and structural correlates of sequence variation in the capsid proteins. Virology (1994) 0.78
Polyclonal activation of B cells during rubella infection. Scand J Immunol (1985) 0.78
Inclusion body myositis and paramyxoviruses. Hum Pathol (1991) 0.78
Mumps and Coxsackie B3 virus infection of human fetal pancreatic islet-like cell clusters. Pancreas (1992) 0.77
Use of enzyme immunoassay and nucleic acid hybridization for detecting Sindbis virus in infected mosquitoes. J Virol Methods (1987) 0.77